Normogonadotropic Hypogonadism Robertsonian Translocation (14;21) & Infertility
Understanding Infertility Linked to Robertsonian Translocation (14;21)
Table of Contents
Published october 23, 2025
the Genetic basis of Infertility
Infertility can stem from a variety of factors, and increasingly, genetic causes are being identified. A specific chromosomal abnormality, Robertsonian translocation involving chromosomes 14 and 21, is now recognized as a critically important contributor to both infertility and a condition called normogonadotropic hypogonadism.
Robertsonian translocation occurs when the long arms of two acrocentric chromosomes (chromosomes with the centromere near one end) fuse at the centromere, resulting in a single, larger chromosome. The short arms are typically lost. While individuals carrying a balanced Robertsonian translocation (14;21) may be phenotypically normal, thay have an increased risk of producing gametes (sperm or eggs) with an unbalanced chromosome complement.
Normogonadotropic Hypogonadism: A Hormonal Imbalance
Normogonadotropic hypogonadism is a condition characterized by low sex hormone levels despite normal levels of gonadotropin hormones (luteinizing hormone and follicle-stimulating hormone).In men, this can manifest as reduced testosterone, leading to decreased libido, erectile dysfunction, and reduced muscle mass. In women, it can result in irregular menstrual cycles or amenorrhea (absence of menstruation) and infertility.
The connection between Robertsonian translocation (14;21) and normogonadotropic hypogonadism lies in the disruption of genes crucial for reproductive growth and function. The translocation can lead to haploinsufficiency – where having only one functional copy of a gene (instead of the usual two) isn’t enough for normal function – of genes located near the translocation breakpoint.
Impact on Reproduction
Individuals with a balanced Robertsonian translocation (14;21) often experience recurrent miscarriages or the birth of children with Down syndrome (trisomy 21). This is because the translocation increases the chance of producing gametes carrying an extra copy of chromosome 21. The risk of producing gametes with an unbalanced chromosome complement is significant, leading to reproductive challenges.
For men, the translocation can lead to severely impaired spermatogenesis (sperm production), often resulting in azoospermia (absence of sperm in the ejaculate). Women may experience difficulties with oocyte (egg) development and implantation.
Diagnosis and management
Diagnosis typically involves chromosomal analysis (karyotyping) to identify the translocation.Genetic counseling is crucial for individuals with a known translocation and those considering family planning.
Management options are limited and often focus on assisted reproductive technologies (ART). Preimplantation genetic testing for aneuploidy (PGT-A) can be used during in vitro fertilization (IVF) to screen embryos for chromosomal abnormalities before implantation, increasing the chances of a prosperous pregnancy with a healthy baby. Hormone replacement therapy might potentially be considered to address the symptoms of normogonadotropic hypogonadism, but it does not correct the underlying genetic cause.